Gideon Strategic Partners logo

Gideon Strategic Partners

North America, California, United States, Santa Monica

Description

Gideon Strategic Partners specializes in asset management, risk management, financial, estate and retirement planning services.

Investor Profile

Gideon Strategic Partners has made 3 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (67%)
  • Series D (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Medical Device
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gideon Strategic Partners frequently co-invest with?

Yu Galaxy
North America, California, United States, Palo Alto
Co-Investments: 1
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
AP
North America, New York, United States, New York
Co-Investments: 1
Eclipse Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Medvest Capital
North America, Florida, United States, Palm Beach Gardens
Co-Investments: 1
Huimei Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Zimmer Biomet
North America, Indiana, United States, Warsaw
Co-Investments: 1
GOS Capital
North America, New Mexico, United States, Albuquerque
Co-Investments: 1
Intuitive Ventures
North America, California, United States, Sunnyvale
Co-Investments: 1
Prism Venture Management
North America, Massachusetts, United States, Needham
Co-Investments: 1

What are some of recent deals done by Gideon Strategic Partners?

SafeHeal

Paris, Ile-de-France, France

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

Health CareMedicalMedical Device
Series CApr 29, 2025
Amount Raised: $39,879,677
Capstan Medical

Santa Cruz, California, United States

Capstan Medical is creating minimally invasive technologies to treat heart valve disorders.

MedicalMedical DeviceRobotics
Series CDec 11, 2024
Amount Raised: $110,000,000
Osteal Therapeutics

Dallas, Texas, United States

Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopedic infections.

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical
Series DJun 5, 2024
Amount Raised: $50,000,000
Osteal Therapeutics

Dallas, Texas, United States

Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopedic infections.

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical
Series CSep 21, 2023
Amount Raised: $23,000,000